Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
9.01
+0.10 (1.12%)
At close: Oct 2, 2026, 4:00 PM EDT
8.96
-0.05 (-0.55%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $59.29 million as of October 2, 2026. Its market cap has increased by 37.39% in one year.
Market Cap
59.29M
Enterprise Value
-70.45M
1-Year Change
37.39%
Ranking
Category
Stock Price
$9.01
ChartMarket Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $59.29M, a decrease of -86.11%. That is a compound annual growth rate of -32.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 59.29M | 76.39% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 62.56M |
| Connect Biopharma Holdings | 62.47M |
| Eloxx Pharmaceuticals | 62.24M |
| Hyperion DeFi | 62.00M |
| Alterity Therapeutics | 61.58M |
| Mereo BioPharma Group | 59.60M |
| Clene | 58.28M |
| Boundless Bio | 58.23M |